Trulieve Cannabis Corp (TRLV) Stock Analysis

Verdict: WATCH (do not buy)

Strong $212M free cash flow and 12% FCF yield support expansion, but severe GAAP earnings misses and federal tax burdens cap near-term upside.

Investment score: 54/100

Analysis as of

Is Trulieve Cannabis Corp stock worth reviewing? AI model thesis

The AI model assesses Trulieve Cannabis Corp as a HOLD at $11.82. The company demonstrates outstanding operating cash generation ($272.82M) and a 12.0% FCF yield, but severe GAAP net profit volatility and negative top-line growth warrant caution near 52-week highs ($12.30).

7-factor investment score

Trulieve Cannabis Corp opportunities and risks

What speaks for TRLV

What speaks against TRLV

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
TRLVn/a1.7x6.9x54.6%-7.0%12.0%
AMRX35.3x1.8x12.7x39.3%5.0%1.5%
TRVIn/a0.0xn/a0.0%0.0%-1.7%
NUVBn/a13.6xn/a93.9%-88.2%-3.6%
RAPPn/a116.6xn/a100.0%-685.8%-4.2%
HRMY12.5x2.4x6.8x75.4%18.9%15.6%
Peer mediann/a2.4xn/a75.4%0.0%-1.7%

Frequently asked questions about Trulieve Cannabis Corp (TRLV)

Is TRLV stock a good investment?

The cached TradeMates AI model rates Trulieve Cannabis Corp as WATCH (do not buy) with an investment score of 54/100. The AI model assesses Trulieve Cannabis Corp as a HOLD at $11.82. The company demonstrates outstanding operating cash generation ($272.82M) and a 12.0% FCF yield, but severe GAAP net profit volatility and negative top-line growth warrant caution near 52-week highs ($12.30). This is algorithmic model output, not personal investment advice.

Is TRLV stock a buy?

The TradeMates model verdict for TRLV is WATCH (do not buy) with an investment score of 54/100. Treat this as a model signal to review, not a personal buy recommendation.